NCT Number,Study Title,Study URL,Acronym,Study Status,Brief Summary,Study Results,Conditions,Interventions,Primary Outcome Measures,Secondary Outcome Measures,Other Outcome Measures,Sponsor,Collaborators,Sex,Age,Phases,Enrollment,Funder Type,Study Type,Study Design,Other IDs,Start Date,Primary Completion Date,Completion Date,First Posted,Results First Posted,Last Update Posted,Locations,Study Documents
NCT00441922,Trial of Docetaxel Versus Vinorelbine as 1st Line Treatment in Elderly Patients With Non-Small-Cell Lung Cancer (NSCLC),https://clinicaltrials.gov/study/NCT00441922,,COMPLETED,This trial will compare the efficacy of docetaxel versus vinorelbine as first-line treatment in elderly patients with advanced NSCLC.,NO,Non Small Cell Lung Cancer,DRUG: Docetaxel|DRUG: Vinorelbine,"Overall survival between the two treatment arms, 1 year","Time to disease progression, 1 year|Toxicity profile, During the time of chemotherapy",,Hellenic Oncology Research Group,University Hospital of Crete,ALL,OLDER_ADULT,PHASE3,166,OTHER,INTERVENTIONAL,Allocation: RANDOMIZED|Intervention Model: PARALLEL|Masking: NONE|Primary Purpose: TREATMENT,CT/03.07,2003-01,2008-01,2008-01,2007-03-01,,2008-10-29,"University General Hospital of Alexandroupolis, Department of Medical Oncology, Alexandroupolis, Greece|401 Military Hospital of Athens, Athens, Greece|Air Forces Military Hospital of Athens, Athens, Greece|IASO General Hospital of Athens, 1st Department of Medical Oncology, Athens, Greece|Laikon General Hospital, Medical Oncology Unit, Propedeutic Department of Internal Medicine, Athens, Greece|Sismanogleio General Hospital, 1st, 2nd Department of Pulmonary Diseases, Athens, Greece|Sotiria General Hospital, 1st, 3rd, 8th Department of Pulmonary Diseases, Athens, Greece|State General Hospital of Larissa, Department of Medical Oncology, Larissa, Greece|Metaxa's Anticancer Hospital of Piraeus, 1st Department of Medical Oncology, Piraeus, Greece|Theagenion Anticancer Hospital of Thessaloniki, Thessaloniki, Greece",
